OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa - PubMed (original) (raw)

OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa

L N Philippon et al. Antimicrob Agents Chemother. 1997 Oct.

Abstract

Clinical isolate Pseudomonas aeruginosa Mus showed resistance both to extended-spectrum cephalosporins and to aztreonam. We detected a typical double-disk synergy image when ceftazidime or aztreonam was placed next to a clavulanic acid disk on an agar plate. This resistance phenotype suggested the presence of an extended-spectrum beta-lactamase. Isoelectric focusing revealed that this strain produced three beta-lactamases, of pI 5.5, 7.4, and 8.2. A 2.6-kb Sau3A fragment encoding the extended-spectrum beta-lactamase of pI 5.5 was cloned from P. aeruginosa Mus genomic DNA. This enzyme, named OXA-18, had a relative molecular mass of 30.6 kDa. OXA-18 has a broad substrate profile, hydrolyzing amoxicillin, ticarcillin, cephalothin, ceftazidime, cefotaxime, and aztreonam, but not imipenem or cephamycins. Its activity was totally inhibited by clavulanic acid at 2 microg/ml. Hydrolysis constants of OXA-18 (Vmax, Km) confirmed the MIC results. Cloxacillin and oxacillin hydrolysis was noticeable with the partially purified OXA-18. The blaOXA-18 gene encodes a 275-amino-acid protein which has weak identity with all class D beta-lactamases except OXA-9 and OXA-12 (45 and 42% amino acid identity, respectively). OXA-18 is likely to be chromosomally encoded since no plasmid was found in the strain and because attempts to transfer the resistance marker failed. OXA-18 is peculiar since it is a class D beta-lactamase which confers high resistance to extended-spectrum cephalosporins and seems to have unique hydrolytic properties among non-class A enzymes.

PubMed Disclaimer

Similar articles

• Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
  Nordmann P, Ronco E, Naas T, Duport C, Michel-Briand Y, Labia R. Nordmann P, et al. Antimicrob Agents Chemother. 1993 May;37(5):962-9. doi: 10.1128/AAC.37.5.962. Antimicrob Agents Chemother. 1993. PMID: 8517722 Free PMC article.
• Genetic structure associated with blaOXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase.
  Naas T, Namdari F, Bogaerts P, Huang TD, Glupczynski Y, Nordmann P. Naas T, et al. Antimicrob Agents Chemother. 2008 Nov;52(11):3898-904. doi: 10.1128/AAC.00403-08. Epub 2008 Jul 28. Antimicrob Agents Chemother. 2008. PMID: 18663027 Free PMC article.
• OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene.
  Poirel L, Girlich D, Naas T, Nordmann P. Poirel L, et al. Antimicrob Agents Chemother. 2001 Feb;45(2):447-53. doi: 10.1128/AAC.45.2.447-453.2001. Antimicrob Agents Chemother. 2001. PMID: 11158739 Free PMC article.
• OXA-type beta-lactamases.
  Naas T, Nordmann P. Naas T, et al. Curr Pharm Des. 1999 Nov;5(11):865-79. Curr Pharm Des. 1999. PMID: 10539993 Review.
• A review on the mechanistic details of OXA enzymes of ESKAPE pathogens.
  Avci FG, Tastekil I, Jaisi A, Ozbek Sarica P, Sariyar Akbulut B. Avci FG, et al. Pathog Glob Health. 2023 May;117(3):219-234. doi: 10.1080/20477724.2022.2088496. Epub 2022 Jun 26. Pathog Glob Health. 2023. PMID: 35758005 Free PMC article. Review.

Cited by

• Molecular, Genetic, and Biochemical Characterization of OXA-484 Carbapenemase, a Difficult-to-Detect R214G Variant of OXA-181.
  Gonzalez C, Oueslati S, Rima M, Nermont R, Dortet L, Hopkins KL, Iorga BI, Bonnin RA, Naas T. Gonzalez C, et al. Microorganisms. 2024 Jul 9;12(7):1391. doi: 10.3390/microorganisms12071391. Microorganisms. 2024. PMID: 39065158 Free PMC article.
• Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.
  Poirel L, Cattoir V, Soares A, Soussy CJ, Nordmann P. Poirel L, et al. Antimicrob Agents Chemother. 2007 Feb;51(2):631-7. doi: 10.1128/AAC.01082-06. Epub 2006 Nov 20. Antimicrob Agents Chemother. 2007. PMID: 17116662 Free PMC article.
• Characterization of OXA-29 from Legionella (Fluoribacter) gormanii: molecular class D beta-lactamase with unusual properties.
  Franceschini N, Boschi L, Pollini S, Herman R, Perilli M, Galleni M, Frère JM, Amicosante G, Rossolini GM. Franceschini N, et al. Antimicrob Agents Chemother. 2001 Dec;45(12):3509-16. doi: 10.1128/AAC.45.12.3509-3516.2001. Antimicrob Agents Chemother. 2001. PMID: 11709332 Free PMC article.
• Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa.
  Rodríguez-Martínez JM, Poirel L, Nordmann P. Rodríguez-Martínez JM, et al. Antimicrob Agents Chemother. 2009 Nov;53(11):4783-8. doi: 10.1128/AAC.00574-09. Epub 2009 Sep 8. Antimicrob Agents Chemother. 2009. PMID: 19738025 Free PMC article.
• OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.
  Poirel L, Marqué S, Héritier C, Segonds C, Chabanon G, Nordmann P. Poirel L, et al. Antimicrob Agents Chemother. 2005 Jan;49(1):202-8. doi: 10.1128/AAC.49.1.202-208.2005. Antimicrob Agents Chemother. 2005. PMID: 15616297 Free PMC article.

References

1. 1. Nucleic Acids Res. 1987 Sep 25;15(18):7491-501 - PubMed
2. 1. FEBS Lett. 1985 Oct 21;191(1):39-44 - PubMed
3. 1. Antimicrob Agents Chemother. 1988 Jan;32(1):134-6 - PubMed
4. 1. Plasmid. 1988 Jan;19(1):21-9 - PubMed
5. 1. Nucleic Acids Res. 1988 Oct 11;16(19):9323-35 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal